Health, pharmaceuticals and biotechnology: where the public money is

BNDES credit for the health complex

• BNDES Finem - Education, Health and Social Assistance: financing to improve and expand education, health and social-assistance services;
• BNDES Finem - Production of pharmaceuticals and medicines: financing for development, modernization and capacity expansion for pharmaceuticals, medicines, medical equipment and materials (formerly BNDES Profarma - Production);
• BNDES Fornecedores SUS: credit tied to supplying the public health system (SUS) with health devices produced in Brazil;
• FIIS - Support for health investments: investment projects and acquisition of machines and equipment for free public care within the SUS, focused on primary and/or specialized care;
• Other applicable lines are in the full BNDES Navigator sweep.

Health innovation and R&D

• Finep: health and biotechnology innovation, under the agency's own modalities;
• FNDCT and EMBRAPII: technological research and development with matching funds;
• BNDES Mais Inovacao: industrial and technological projects, in the Navigator sweep;
• Lei do Bem: R&D tax incentive for companies under the taxable-income regime.

Health industrial policy - not credit

• Health Economic-Industrial Complex (CEIS): the federal strategy to strengthen domestic production;
• Productive Development Partnerships (PDP): technology transfer with a public-procurement commitment by the SUS - an industrial-policy instrument, accessed through Ministry of Health public selection;
• Ministry of Health calls: projects selected through specific public calls.

Who usually qualifies

• Pharmaceutical industry, manufacturers of medicines, inputs and vaccines;
• Hospital and dental equipment, medical devices and diagnostics;
• Laboratories, biotechnology and clinical and technological research.

Sources

BNDES Navigator; Ministry of Health - CEIS and PDP. All checked on November 2, 2026. Final conditions depend on each instrument's rules.